| |
| |
|
| Insider
Information: |
Shefferman Jesse |
| Relationship: |
|
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
944,064 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,153,174 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
944,064 |
|
|
| Total
Value |
$3,153,174 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Protara Therapeutics, Inc |
TARA |
|
2024-01-19 |
944,064 |
2020-01-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TARA |
Protara Therapeutics, Inc |
CEO and President |
• • – |
2024-01-19 |
4 |
D |
$1.91 |
$14,904 |
D/D |
(7,803) |
944,064 |
0 |
- |
|
| TARA |
Protara Therapeutics, Inc |
CEO and President |
• • – |
2024-01-19 |
4 |
A |
$0.00 |
$0 |
D/D |
59,000 |
951,867 |
0 |
- |
|
| TARA |
Protara Therapeutics, Inc |
CEO and President |
• • – |
2024-01-10 |
4 |
D |
$2.39 |
$13,733 |
D/D |
(5,746) |
892,867 |
0 |
- |
|
| TARA |
Protara Therapeutics, Inc |
CEO and President |
• • – |
2024-01-03 |
4 |
D |
$2.17 |
$12,673 |
D/D |
(5,840) |
898,613 |
0 |
- |
|
| TARA |
Protara Therapeutics, Inc |
CEO and President |
• • – |
2023-06-27 |
4 |
GD |
$0.00 |
$0 |
D/D |
7,420 |
904,453 |
0 |
- |
|
| TARA |
Protara Therapeutics, Inc |
CEO and President |
• • – |
2023-06-23 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,890 |
911,873 |
0 |
- |
|
| TARA |
Protara Therapeutics, Inc |
CEO and President |
• • – |
2023-01-19 |
4 |
A |
$0.00 |
$0 |
D/D |
51,300 |
918,282 |
0 |
- |
|
| TARA |
Protara Therapeutics, Inc |
CEO and President |
• • – |
2023-01-10 |
4 |
D |
$3.00 |
$17,565 |
D/D |
(5,855) |
866,982 |
0 |
- |
|
| TARA |
Protara Therapeutics, Inc |
CEO and President |
• • – |
2023-01-03 |
4 |
D |
$2.80 |
$18,491 |
D/D |
(6,604) |
872,837 |
0 |
- |
|
| TARA |
Protara Therapeutics, Inc |
CEO and President |
• • – |
2022-08-11 |
4 |
B |
$3.84 |
$34,810 |
D/D |
9,065 |
879,441 |
2.81 |
% |
|
| TARA |
Protara Therapeutics, Inc |
CEO and President |
• • – |
2022-01-10 |
4 |
D |
$6.27 |
$31,852 |
D/D |
(5,080) |
872,425 |
0 |
- |
|
| TARA |
Protara Therapeutics, Inc |
CEO and President |
• • – |
2022-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
42,300 |
877,505 |
0 |
- |
|
| TARA |
Protara Therapeutics, Inc |
CEO and President |
• • – |
2021-01-11 |
4 |
D |
$21.16 |
$107,260 |
D/D |
(5,069) |
835,205 |
0 |
- |
|
| TARA |
Protara Therapeutics, Inc |
CEO and President |
• • – |
2020-01-10 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
840,274 |
0 |
- |
|
| TARA |
Protara Therapeutics, Inc |
CEO and President |
• • – |
2020-01-09 |
4 |
A |
$0.00 |
$0 |
D/D |
790,274 |
790,274 |
0 |
- |
|
15 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
